I like how Cathie Wood looks at innovation but some of her recent trades are a little brow-raising. TeleDoc$Teladoc Health Inc.(TDOC)$ deals with telemedicine and it acquired Livongo and BetterHelp during the pandemic to boost its platform telemedicine services. Eye-popping acquisitions with exorbitant prices. While I walked out with good profits on the investment and thereafter, the market sold down 90% from TDOC's peak. 

Is the business bad? Revenues are still growing 25% yoy, with the write down on paper losses of Livongo weighing huge. There's still a future for telemedicine and a good ecosystem built by TDOC. But it will take a while before Wood even breaks even. 

The 2020-2022 period is a good learning point for investors. One is to learn when to take profits off the table, especially when graphs go on a huge vertical climb, unsustainable. 

My take on the future for telemedicine:

Huge TAM, albeit rising competition. Sometimes it may be better to specialise than to be all things to all men. There are many platforms seeking to be the next few Amazons in telemedicine. Plenty of room certainly and I think the ones with the best specialised niches within the platform with the beat margins will win in the long haul. 

Will I return to TDOC after it just got slaughtered so much? Well, it is getting to an attractive price point. But with the #NDX still yet to get crushed, I think there is something slightly lower that can be achieved. Puts will come in handy shortly.